Loading clinical trials...
Loading clinical trials...
This is a dissemination and implementation study that is evaluating a stepped-care intervention for identifying and treating youths at clinical high-risk for psychosis within multiple community mental...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of California, Davis
Collaborators
NCT07226895 · Clinical High Risk for Psychosis (CHR)
NCT05968560 · Clinical High Risk for Psychosis (CHR)
NCT05827900 · Ultra-high Risk for Psychosis, Clinical High Risk for Psychosis, and more
NCT05509998 · First Episode Psychosis (FEP), Clinical High Risk for Psychosis (CHR)
NCT07434973 · Clinical High Risk for Psychosis (CHR), Clinical High Risk for Psychosis, and more
River Oak Center for Children
Elk Grove, California
Turning Point Community Programs
Elk Grove, California
University of California Department of Psychiatry and Behavioral Sciences; Early Psychosis Programs
Sacramento, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions